Livforsakringsbolaget Skandia Omsesidigt lessened its holdings in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 75.3% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,200 shares of the health services provider's stock after selling 21,900 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt's holdings in Universal Health Services were worth $1,304,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of UHS. Zions Bancorporation National Association UT bought a new position in Universal Health Services during the first quarter valued at approximately $30,000. Sentry Investment Management LLC acquired a new position in shares of Universal Health Services in the 1st quarter valued at $35,000. UMB Bank n.a. boosted its position in shares of Universal Health Services by 49.3% during the 1st quarter. UMB Bank n.a. now owns 203 shares of the health services provider's stock valued at $38,000 after acquiring an additional 67 shares during the last quarter. Federated Hermes Inc. increased its stake in shares of Universal Health Services by 89.7% during the first quarter. Federated Hermes Inc. now owns 258 shares of the health services provider's stock worth $48,000 after buying an additional 122 shares during the period. Finally, CX Institutional acquired a new stake in shares of Universal Health Services during the first quarter worth $74,000. 86.05% of the stock is currently owned by hedge funds and other institutional investors.
Universal Health Services Stock Up 0.3%
Shares of UHS traded up $0.52 on Friday, hitting $188.63. 1,396,397 shares of the stock traded hands, compared to its average volume of 651,998. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.19 and a current ratio of 1.29. Universal Health Services, Inc. has a one year low of $152.33 and a one year high of $243.25. The business has a 50 day simple moving average of $176.70 and a 200 day simple moving average of $179.00. The company has a market capitalization of $12.00 billion, a PE ratio of 9.93, a P/E/G ratio of 0.78 and a beta of 1.28.
Universal Health Services (NYSE:UHS - Get Free Report) last posted its earnings results on Monday, July 28th. The health services provider reported $5.35 earnings per share for the quarter, topping analysts' consensus estimates of $4.85 by $0.50. Universal Health Services had a net margin of 7.66% and a return on equity of 18.25%. The firm had revenue of $4.28 billion for the quarter, compared to the consensus estimate of $4.24 billion. During the same period in the previous year, the firm posted $4.31 EPS. The business's quarterly revenue was up 9.6% on a year-over-year basis. Universal Health Services has set its FY 2025 guidance at 20.000-21.000 EPS. As a group, equities analysts forecast that Universal Health Services, Inc. will post 15.92 earnings per share for the current fiscal year.
Universal Health Services Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 16th. Shareholders of record on Tuesday, September 2nd were given a dividend of $0.20 per share. The ex-dividend date was Tuesday, September 2nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.4%. Universal Health Services's dividend payout ratio (DPR) is currently 4.21%.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on UHS shares. UBS Group set a $227.00 price objective on Universal Health Services in a research report on Wednesday, July 30th. Wall Street Zen cut Universal Health Services from a "strong-buy" rating to a "buy" rating in a report on Saturday, September 13th. Cantor Fitzgerald restated a "neutral" rating and issued a $227.00 price target on shares of Universal Health Services in a report on Tuesday, August 26th. Royal Bank Of Canada upped their price target on Universal Health Services from $201.00 to $206.00 and gave the company a "sector perform" rating in a research report on Tuesday, August 19th. Finally, JPMorgan Chase & Co. decreased their target price on Universal Health Services from $215.00 to $195.00 and set a "neutral" rating for the company in a research note on Monday, August 4th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $214.08.
View Our Latest Report on UHS
Universal Health Services Profile
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Read More

Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.